TP53 and osteoporosis: In addition, qRT-PCR and Alizarin-red staining showed that MDM2-mediated inhibition of p53 induced osteoblast differentiation in vitro (Figure 6C–6G), indicating that p53 promoted the pathological progression of osteoporosis.